This site is for Singapore residents.

Spikevax XFG

0.1 mg/mL dispersion for injection in multi-dose vial
50 micrograms dispersion for injection in pre-filled syringe

Approved indication
• Multi-dose vial: Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.
• Pre-filled syringe: Active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older.

Patient Information Leaflet for multi-dose vial

Download now

Summary of Product Characteristics for multi-dose vial

Patient Information Leaflet for pre-filled syringe

Summary of Product Characteristics for pre-filled syringe